Hyung-koo Rhee
Kyung Hee University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hyung-koo Rhee.
Immunopharmacology and Immunotoxicology | 2004
Hwan-Suck Chung; Seung-Heon Hong; Keum‐Rok Do; Hyung-koo Rhee; Sung-Ki Jung; Woo-Jun Hwang; Hyung-Min Kim
MooPoong (MP, Gye Young Jeong), a Korean traditional wine, has been used as a prevention and treatment agent of blood circulatory trouble. To evaluate such an effect of MP, we analyzed whether the plasma levels of low‐density lipoprotein (LDL) cholesterol, high‐density lipoprotein (HDL) cholesterol, and body weight change after rats were fed on high fat diet with MP for 8 weeks. Plasma LDL cholesterol level decreased by 5.6% in 0.128% MP treated group and by 11.1% in 0.640% MP treated group. However, HDL cholesterol was increased by 6.7% in 0.128% MP diet group and 33.3% in 0.640% MP diet group. In addition, there was a significant weight loss in the MP treated group compared with the high‐fat diet group (P < 0.05). Our findings indicate that MP may contain compounds with actions which can treat blood circulatory trouble as well as overweight.
Oriental Pharmacy and Experimental Medicine | 2004
Seung-Heon Hong; Myung-Jin Oh; Eon-Jeong Lee; Jin-Han Park; Na-Hyung Kim; Hyung-koo Rhee; Hyung-Min Kim; Sung-Ki Jung
The effect of aqueous extract of processed Xanthii fructus (PXF) on cell viability and histamine release from mast cell has been investigated. PXF showed higher cell viability than unprocessed Xanthii fructus (XF) at the concentrations of 5 and 10 mg/ml. Aqueous extract of PXF and unprocessed XF inhibited compound 48/80-induced systemic anaphylaxis in mouse. Both PXF and unprocessed XF dose-dependently inhibited histamine release from rat peritoneal mast cells by compound 48/80 to the similar extent at 0.01, 0.1 and 1 mg/ml. Our studies provide evidence that processing of XF may be beneficial to reduce cytotoxicity in high concentration (at 5 and 10 mg/ml) but does not affect on anti-allergic activity.
Biological & Pharmaceutical Bulletin | 2005
Su-Jin Kim; Hyun-Ja Jeong; Phil-Dong Moon; Kang-Min Lee; Hong-Beom Lee; Hee-jae Jung; Sung-Ki Jung; Hyung-koo Rhee; Deok-Chun Yang; Seung-Heon Hong; Hyung-Min Kim
The Journal of Internal Korean Medicine | 2008
Kun-young Lee; Hyung-koo Rhee; Sung-Ki Jung; Hee-jae Jung
The Journal of Internal Korean Medicine | 2008
Sung-hun Lee; Jae-hwan Kim; Young-lae Roh; Hyung-koo Rhee; Seung-yeon Jeong; Sung-Ki Jung; Hee-jae Jung
The Journal of Internal Korean Medicine | 2004
Jun-Yong Choi; Jae-Sung Lee; Seung-yeon Jeong; Kun-young Lee; Kyung-ki Lee; Hee-jae Jung; Hyung-koo Rhee; Sung-Ki Jung
The Journal of Internal Korean Medicine | 2008
Jin-yong Jung; Sung-Ki Jung; Hee-jae Jung; Hyung-koo Rhee
The Journal of Internal Korean Medicine | 2008
Byeong-sam Lee; Hong-yeoul Kim; Jinju Kim; Sung-Ki Jung; Hyung-koo Rhee; Hee-jae Jung
The Journal of Internal Korean Medicine | 2007
Jeong-woo Lee; Hyung-koo Rhee; Hee-jae Jung
The Journal of Internal Korean Medicine | 2006
Dong-hee Park; Hyung-koo Rhee; Sung-Ki Jung; Hee-jae Jung